Berger Montague Announces that its False Claims Act Whistleblower Case Against CVS Health Will Move Forward to Trial
PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.
- PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.
- The case is brought under the False Claims Act which allows private individuals to bring claims on behalf of the government to recover for fraud against the government.
- In its summary judgment decision, the Court rejected the CVS Health defendants' attempt to have the claims dismissed without trial.
- We are very pleased with the Court's ruling and look forward to presenting our case to a jury at trial," said Sorensen.